Bittner, V. A., Szarek, M., Aylward, P., Bhatt, D. L., Diaz, R., Edelberg, J. M., . . . Bruguera Cortada, J. (2020). Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.
Citación estilo ChicagoBittner, Vera A., et al. Effect of Alirocumab On Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome. 2020.
Cita MLABittner, Vera A., et al. Effect of Alirocumab On Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome. 2020.
Precaución: Estas citas no son 100% exactas.